TTKHLTCARE2024-07-012024-09-30 TTKHLTCARE2024-07-012024-09-30 TTKHLTCARE2024-07-012024-09-30in-bse-fin:OneOperatingExpenses01Member TTKHLTCARE2024-07-012024-09-30in-bse-fin:FourOperatingExpenses01Member TTKHLTCARE2024-09-30 TTKHLTCARE2024-07-012024-09-30in-bse-fin:OneReportableSegmentRevenue01Member TTKHLTCARE2024-07-012024-09-30in-bse-fin:OneReportableSegmentRevenue02Member TTKHLTCARE2024-07-012024-09-30in-bse-fin:OneReportableSegmentRevenue03Member TTKHLTCARE2024-07-012024-09-30in-bse-fin:OneReportableSegmentRevenue04Member TTKHLTCARE2024-07-012024-09-30in-bse-fin:OneReportableSegmentRevenue05Member TTKHLTCARE2024-07-012024-09-30in-bse-fin:OneReportableSegmentRevenue06Member TTKHLTCARE2024-07-012024-09-30in-bse-fin:FourReportableSegmentRevenue01Member TTKHLTCARE2024-07-012024-09-30in-bse-fin:FourReportableSegmentRevenue02Member TTKHLTCARE2024-07-012024-09-30in-bse-fin:FourReportableSegmentRevenue03Member TTKHLTCARE2024-07-012024-09-30in-bse-fin:FourReportableSegmentRevenue04Member TTKHLTCARE2024-07-012024-09-30in-bse-fin:FourReportableSegmentRevenue05Member TTKHLTCARE2024-07-012024-09-30in-bse-fin:FourReportableSegmentRevenue06Member TTKHLTCARE2024-07-012024-09-30in-bse-fin:OneReportableSegmentResults01Member TTKHLTCARE2024-07-012024-09-30in-bse-fin:OneReportableSegmentResults02Member TTKHLTCARE2024-07-012024-09-30in-bse-fin:OneReportableSegmentResults03Member TTKHLTCARE2024-07-012024-09-30in-bse-fin:OneReportableSegmentResults04Member TTKHLTCARE2024-07-012024-09-30in-bse-fin:OneReportableSegmentResults05Member TTKHLTCARE2024-07-012024-09-30in-bse-fin:OneReportableSegmentResults06Member TTKHLTCARE2024-07-012024-09-30in-bse-fin:FourReportableSegmentResults01Member TTKHLTCARE2024-07-012024-09-30in-bse-fin:FourReportableSegmentResults02Member TTKHLTCARE2024-07-012024-09-30in-bse-fin:FourReportableSegmentResults03Member TTKHLTCARE2024-07-012024-09-30in-bse-fin:FourReportableSegmentResults04Member TTKHLTCARE2024-07-012024-09-30in-bse-fin:FourReportableSegmentResults05Member TTKHLTCARE2024-07-012024-09-30in-bse-fin:FourReportableSegmentResults06Member TTKHLTCARE2024-07-012024-09-30in-bse-fin:OneReportableSegmentAssets01Member TTKHLTCARE2024-07-012024-09-30in-bse-fin:OneReportableSegmentAssets02Member TTKHLTCARE2024-07-012024-09-30in-bse-fin:OneReportableSegmentAssets03Member TTKHLTCARE2024-07-012024-09-30in-bse-fin:OneReportableSegmentAssets04Member TTKHLTCARE2024-07-012024-09-30in-bse-fin:OneReportableSegmentAssets05Member TTKHLTCARE2024-07-012024-09-30in-bse-fin:OneReportableSegmentAssets06Member TTKHLTCARE2024-07-012024-09-30in-bse-fin:OneReportableSegmentLiabilities01Member TTKHLTCARE2024-09-30in-bse-fin:OneReportableSegmentLiabilities01Member TTKHLTCARE2024-07-012024-09-30in-bse-fin:OneReportableSegmentLiabilities02Member TTKHLTCARE2024-09-30in-bse-fin:OneReportableSegmentLiabilities02Member TTKHLTCARE2024-07-012024-09-30in-bse-fin:OneReportableSegmentLiabilities03Member TTKHLTCARE2024-09-30in-bse-fin:OneReportableSegmentLiabilities03Member TTKHLTCARE2024-07-012024-09-30in-bse-fin:OneReportableSegmentLiabilities04Member TTKHLTCARE2024-09-30in-bse-fin:OneReportableSegmentLiabilities04Member TTKHLTCARE2024-07-012024-09-30in-bse-fin:OneReportableSegmentLiabilities05Member TTKHLTCARE2024-09-30in-bse-fin:OneReportableSegmentLiabilities05Member TTKHLTCARE2024-07-012024-09-30in-bse-fin:OneReportableSegmentLiabilities06Member TTKHLTCARE2024-09-30in-bse-fin:OneReportableSegmentLiabilities06Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 507747 TTKHLTCARE NOTLISTED TTK Healthcare Limited Equity 2024-04-01 2025-03-31 2024-10-25 2024-10-14 INR Lakhs Half yearly 12:00:00 13:00:00 2024-10-25 2024-10-25 true Cash Flow Indirect Not applicable Multi segment 2024-07-01 2024-09-30 Unaudited Standalone 1984869000.00 177029000.00 2161898000.00 496551000.00 489178000.00 -87250000.00 377210000.00 7383000.00 20046000.00 626900000.00 1930018000.00 231880000.00 0.00 231880000.00 59500000.00 369000.00 59869000.00 0.00 172011000.00 0.00 0.00 0.00 0.00 172011000.00 13139000.00 185150000.00 0.00 0.00 141303000.00 10 12.17 12.17 0.00 0.00 12.17 12.17 Notes: (1) The above financial results for the Second Quarter and Half-year ended 30th September, 2024 in respect of TTK Healthcare Limited (the Company) have been reviewed by the Audit Committee at its meeting held on 24th October, 2024 and approved by the Board of Directors of the Company at its meeting held on October 25, 2024 at the Registered Office of the Company, also with the provision of Video Conferencing facility. (2) The Statutory Auditors of the Company have carried out Limited Review of the above Unaudited Financial Results in terms of Regulations 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. (3) During the First Quarter of this financial year, the Company had sold Leasehold land with building at Mahindra World City, Chennai for a consideration of Rs.2,300 lakhs and the profit on sale amounting to Rs.1,977.05 lakhs (Net) has been considered in the above results. (4) Implementation of the Code of Social Security 2020, which is likely to impact the contributions by the Company towards Provident Fund, Gratuity and other related areas has been deferred by the Government beyond April 01, 2021. However, the Company based on the initial assessment made a provision for Rs.350 lakhs in the Fourth Quarter of FY 2020-21 and proposes to take further appropriate action after the Rules are made applicable. (5) The previous period's / year's figures have been regrouped and reclassified, wherever necessary to conform to the current period's / year's presentation. (6) This statement is also available on the website of BSE Limited (www.bseindia.com), National Stock Exchange of India Limited (www.nseindia.com) and also on the website of the Company (www.ttkhealthcare.com). Multi segment 2024-04-01 2024-09-30 Unaudited Standalone 4063890000.00 347293000.00 4411183000.00 991012000.00 945162000.00 -102367000.00 760818000.00 15962000.00 40560000.00 1317918000.00 3969065000.00 442118000.00 197705000.00 639823000.00 153000000.00 -939000.00 152061000.00 0.00 487762000.00 0.00 0.00 0.00 0.00 487762000.00 32086000.00 519848000.00 0.00 0.00 141303000.00 10 34.52 34.52 0.00 0.00 34.52 34.52 Other Expenses 626900000.00 Other Expenses 1317918000.00 740205000.00 53063000.00 0.00 5000.00 162661000.00 0.00 0.00 34422000.00 197083000.00 50378000.00 40729000.00 1081463000.00 1052854000.00 0.00 958144000.00 94860000.00 7833492000.00 0.00 1484844000.00 10371340000.00 9545000.00 150862000.00 11584601000.00 0.00 0.00 12666064000.00 141303000.00 10246431000.00 10387734000.00 10387734000.00 0.00 5842000.00 5842000.00 30607000.00 0.00 0.00 0.00 36449000.00 301121000.00 1194705000.00 458454000.00 1954280000.00 32435000.00 189586000.00 65580000.00 2241881000.00 2278330000.00 12666064000.00 Animal Welfare 318385000.00 Consumer Products 595067000.00 Foods 321436000.00 Medicl Devices 215221000.00 Others 898000.00 Protective Devices 533862000.00 Animal Welfare 629504000.00 Consumer Products 1326495000.00 Foods 648437000.00 Medicl Devices 461008000.00 Others 1701000.00 Protective Devices 996745000.00 1984869000.00 4063890000.00 0.00 0.00 1984869000.00 4063890000.00 Animal Welfare 26501000.00 Consumer Products 81104000.00 Foods 6522000.00 Medicl Devices 48472000.00 Others 961000.00 Protective Devices -19368000.00 Animal Welfare 48061000.00 Consumer Products 141481000.00 Foods 17381000.00 Medicl Devices 104701000.00 Others 1654000.00 Protective Devices -34804000.00 144192000.00 278474000.00 7383000.00 15962000.00 -95071000.00 Notes: 1. Segments have been identified in line with the Indian Accounting Standard on Segment Reporting (Ind AS 108) based on review of performance by the Top Management. 2. Details of products included in each of the Segments are as below: (a) Animal Welfare comprise products for Veterinary use. (b) Consumer Products comprise marketing and distribution of Woodward's Gripewater, EVA Range of Cosmetics, Good Home range of Scrubbers, Air Fresheners, etc. (c) Medical Devices include Artificial Heart Valves, Orthopaedic Implants, etc. (d) Protective Devices comprise manufacturing and marketing of Male Contraceptives and other allied products. (e) Foods comprise manufacturing and marketing of Food Products. (f) Others include Printing and Publishing of Maps and Atlases. 3. The segment wise revenue, results, assets and liabilities figures relate to respective amounts directly identifiable to each of the segments. The unallocable expenditure includes expenses incurred on common services at the corporate level and also those expenses not identifiable to any specific segment. 4. The previous period's / year's figures have been regrouped and reclassified, wherever necessary to conform to the current period's / year's presentation. -377311000.00 231880000.00 639823000.00 Animal Welfare 431667000.00 Consumer Products 437642000.00 Foods 666679000.00 Medicl Devices 660252000.00 Others 29403000.00 Protective Devices 1415081000.00 3640724000.00 9025340000.00 12666064000.00 Animal Welfare 322559000.00 Consumer Products 647506000.00 Foods 154094000.00 Medicl Devices 151541000.00 Others 14972000.00 Protective Devices 494111000.00 1784783000.00 493547000.00 2278330000.00 15962000.00 -82956000.00 -97381000.00 0.00 30341000.00 0.00 0.00 0.00 0.00 172032000.00 0.00 -38947000.00 0.00 40560000.00 -209480000.00 0.00 0.00 0.00 0.00 193000.00 1065000.00 343280000.00 0.00 0.00 0.00 0.00 1997000.00 0.00 0.00 -512024000.00 127799000.00 0.00 0.00 0.00 88415000.00 0.00 39384000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 230989000.00 102135000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1065000.00 279070000.00 0.00 -391288000.00 0.00 17701000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 86391000.00 0.00 2867000.00 0.00 141303000.00 14039000.00 0.00 0.00 -71818000.00 -14733000.00 0.00 -14733000.00 109593000.00 94860000.00 16740000.00 37082000.00 3601000.00 4996000.00